The history of differentiating Linde Gas Therapeutics from an industrial supplier of medical gases into a pharmaceutical gas company was initiated in the mid nineties. Since that time we have consistently improved our processes and created documented, quality products to help the medical community care more effectively.
The name, Linde Gas Therapeutics, reflects our offering of therapy solutions, not simply gas and equipment.
Our company has worked globally to drive the quality upgrading process. In this we are now supported by the regulatory authorities, with Europe as the front runner, so that what were formerly medical gases are now regulated medicinal products and medical devices. Our experience in developing inhaled nitric oxide (NO) as a pharmaceutical through all phases, gave us a head start and invaluable competence.
Our focus on R&D will lead to new products and new indications and uses for existing products in the years to come.